glp-1 compound tirzepatide Injectable | Compounded GLP-1/GIP weekly GLP Tirzepatide | Quality Compounding

Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, et al

Multi-dimensional formula addresses the facial changes that occur when using GLP-1 agonists Formula works in 4D to improve the appearance of facial skin deflation, loose, sagging, crepey skin texture, dehydration, and deep wrinkles Proprietary XOSM technology boosts formula performance Improves the appearance of skin firmness, density and skin texture quality Deeply nourishes and hydrates, plumping the skin Protects and nourishes the skins barrier 20.1% increase in facial volume 22.5% increase in firmness 23.2% increase in net elasticity 20.7% decrease in wrinkles 21.8% increase in hydration Disclaimer: Based on a 12-week clinical study of 29 participants ages 3565, who have experienced weight loss due to the use of one of the following: GLP-1 agonists, GIP, other weight loss promoting drugs or gastric bypass surgery, with twice daily application of VOL.U.LIFT

Impact on healthcare An increased uptake of GLP-1 agonists will undoubtedly affect the healthcare industry

Taraschi F, Salgarello M

As GLP-1 medications become more widely used for metabolic health and weight management, interest in needle-free alternatives has surged

If you have recently started or adjusted doses of these medications, they may be the primary cause of increased urination